Skip to main content
See every side of every news story
Published • loading... • Updated

AZ Boosts Vaccine Capabilities with Omniose Buy

Summary by Pharmaphorum
AstraZeneca has bought a US biotech developing polysaccharide conjugate vaccines for bacterial infections, Omniose, after a three-year partnership.

4 Articles

AstraZeneca has reinforced its commitment to vaccines. And it has done so with the acquisition of Omniose, an American biotechnology company specialized in the development of conjugated vaccines against serious bacterial infections. The company, based in St. Louis (Misuri), will be integrated into the Division of Infectious Diseases of the British laboratory, according to Omniose [...] The entry AstraZeneca acquires Omniose to strengthen its vac…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Pharmaphorum broke the news on Wednesday, November 11, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal